Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer.

MLA

Jiménez-Vacas, Juan M., et al. “Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer.” Journal of Clinical Medicine, vol. 8, no. 12, Nov. 2019. EBSCOhost, https://doi.org/10.3390/jcm8122056.

APA

Jiménez-Vacas, J. M., Gómez-Gómez, E., Montero-Hidalgo, A. J., Herrero-Aguayo, V., L-López, F., Sánchez-Sánchez, R., Guler, I., Blanca, A., Méndez-Vidal, M. J., Carrasco, J., Lopez-Miranda, J., Requena-Tapia, M. J., Castaño, J. P., Gahete, M. D., & Luque, R. M. (2019). Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer. Journal of Clinical Medicine, 8(12). https://doi.org/10.3390/jcm8122056

Chicago

Jiménez-Vacas, Juan M, Enrique Gómez-Gómez, Antonio J Montero-Hidalgo, Vicente Herrero-Aguayo, Fernando L-López, Rafael Sánchez-Sánchez, Ipek Guler, et al. 2019. “Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer.” Journal of Clinical Medicine 8 (12). doi:10.3390/jcm8122056.